Researchers in Australia have identified a drug that can help overcome treatment resistance in relapsed neuroblastoma -- the deadly childhood cancer. 

The discovery could improve neuroblastoma treatment -- the most common solid tumour in children outside the brain -- which currently claims nine out of 10 young patients who experience recurrence, Xinhua news agency reported